Peter Teismann

9.6k citations

60 papers · 7.7k indexed · 3 hit papers · h-index 39

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments 30
- Neuroinflammation and Neurodegeneration Mechanisms 14
- Amyotrophic Lateral Sclerosis Research 5
Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 30
- Neuroinflammation and Neurodegeneration Mechanisms 14
- Amyotrophic Lateral Sclerosis Research 5
Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases 10
- Nerve injury and regeneration 9
- Nuclear Receptors and Signaling 7
- Neuroscience and Neuropharmacology Research 6
Biological Psychiatry top 2%
Clinical Biochemistry top 0.5%
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 5

Co-authors: Serge Przedborski Miquel Vila Kim Tieu Vernice Jackson‐Lewis Dong‐Kug Choi Boris Ferger Jörg B. Schulz Du‐Chu Wu
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Annals of Neurology (5 papers)Journal of Neurochemistry (4 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Peter Teismann

60 papers receiving 7.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 Proceedings of the National Academy of Sciences
2003 Proceedings of the National Academy of Sciences
2002 Journal of Neuroscience

Peers

Countries citing papers authored by Peter Teismann

Since Specialization

Citations

This map shows the geographic impact of Peter Teismann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Teismann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Teismann more than expected).

Fields of papers citing papers by Peter Teismann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Teismann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Teismann. The network helps show where Peter Teismann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Teismann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Teismann Line = papers co-authored together Peter Teismann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease Neuroscience ·Sarah Mustafa,Heather L. Martin,Linda C. Burkly,Ana Carolina Oliveira Costa,徐天秀,Markus Schwaninger,Peter Teismann	2016	10
2	Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Experimental Neurology ·Ross B. Mounsey,Sarah Mustafa,Lianne Robinson,Ruth A. Ross,Gernot Riedel,Roger G. Pertwee,Peter Teismann	2015	56
3	Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms Brain ·Céline Perier,Andreas Bender,Elena García‐Arumí,M Melia,Jordi Bové,X. Y. Chen,Thomas Klopstock,Matthias Elstner,Ross B. Mounsey,Peter Teismann,Tomas A. Prolla,Antoni L. Andreu,Miquel Vila	2013	58
4	S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway Brain ·Urfan,Walter Maetzler,Johannes Lang,Ross B. Mounsey,محمد كاظم حسين شريدة,Heather L. Martin,Claudia Schulte,Sarah Mustafa,Matthis Synofzik,Jordi Piñero Subirana,Shigeyoshi Itohara,Daniela Berg,Peter Teismann	2012	170
5	Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease Experimental Neurology ·Heather L. Martin,Ross B. Mounsey,Sarah Mustafa,Urfan,Peter Teismann	2012	59
6	COX‐2 in the neurodegenerative process of Parkinson's disease BioFactors ·Peter Teismann	2012	76
7	Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages Neurobiology of Disease ·Silke Nuber,Elisabeth Petrasch‐Parwez,Óscar Arias-Carrión,Heru Purboyo Hidayat,Zacharias Kohl,G LAUTZ,Carsten Calaminus,Rolf Dermietzel,Ngan-pun Ngai,Jana Boy,Huu Phuc Nguyen,Peter Teismann,Thirumalaisamy P. Velavan,Philipp J. Kahle,Stephan von Hörsten,Markus Fendt,Rejko Krüger,Olaf Rieß	2011	23
8	MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress Naunyn-Schmiedeberg s Archives of Pharmacology ·Ya‐Ching Hsieh,Ross B. Mounsey,Peter Teismann	2011	27
9	Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response Cell Death and Differentiation ·Nicoleta Moisoi,Kristina Klupsch,Valentina Fedele,Philip East,Sushant Sharma,Alan E. Renton,Hélène Plun‐Favreau,Richard Edwards,Peter Teismann,Mauro Degli Esposti,Alastair Morrison,Nicholas Wood,Julian Downward,L. Miguel Martins	2008	143
10	Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's disease Journal of Neurochemistry ·Katrin Meuer,Claudia Pitzer,Peter Teismann,Carola Krüger,Bettina Göricke,Rico Laage,Paul Lingor,Robert L. Smith,Johannes C. M. Schlachetzki,Kazuto Kobayashi,Gunnar P.H. Dietz,Daniela Weber,Boris Ferger,Wolf‐Rüdiger Schäbitz,Alfred Bach,Jörg B. Schulz,Mathias Bähr,Armin Schneider,Jochen H. Weishaupt	2006	103
11	Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice Journal of Neuroscience ·Dong‐Kug Choi,Subramaniam Pennathur,Céline Perier,Kim Tieu,Peter Teismann,Llewellyn Huw,Vernice Jackson‐Lewis,Miquel Vila,Jean-Paul G. Vonsattel,Jay W. Heinecke,Serge Przedborski	2005	238
12	Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice Molecular and Cellular Biology ·L. Miguel Martins,Alastair Morrison,Kristina Klupsch,Valentina Fedele,Nicoleta Moisoi,Peter Teismann,Alejandro Abuin,Evelyn Grau,Martin Geppert,George P. Livi,Caretha L. Creasy,Alison Martin,Iain P. Hargreaves,Simon Heales,Hitoshi Okada,Sebastian Brandner,Jörg B. Schulz,Tak W. Mak,Julian Downward	2004	315
13	D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease Journal of Clinical Investigation ·Kim Tieu,Céline Perier,Casper Caspersen,Peter Teismann,Du‐Chu Wu,Shi-Du Yan,Ali Naini,Miquel Vila,Vernice Jackson‐Lewis,Ravichandran Ramasamy,Serge Przedborski	2003	357
14	Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS Annals of Neurology ·Daniel B. Drachman,Tia Ramadanis,Margaret Dykes‐Hoberg,Peter Teismann,M. Kobes,Serge Przedborski,Jeffrey D. Rothstein	2002	241
15	Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals Journal of Neuroscience Methods ·Bedingte Unabhängigkeiten,Peter Teismann,K. Kuschinsky,Boris Ferger	2001	32
16	Effects of ensaculin on dopamine metabolite levels and K+-induced glutamate release European Journal of Pharmacology ·Peter Teismann,Boris Ferger	2000	7
17	The salicylate hydroxylation assay to measure hydroxyl free radicals induced by local application of glutamate in vivo or induced by the Fenton reaction in vitro Brain Research Protocols ·Peter Teismann,Boris Ferger	2000	43
18	The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study Brain Research ·Boris Ferger,Peter Teismann,Joachim Mierau	2000	45
19	In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(DI-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxypheny-lacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Peter Teismann,Boris Ferger	2000	7
20	Malonate‐Induced Generation of Reactive Oxygen Species in Rat Strium Depends on Dopamine Release but Not on NMDA Receptor Activation Journal of Neurochemistry ·Boris Ferger,O. Eberhardt,Peter Teismann,楼灿,Jörg B. Schulz	1999	54

About Peter Teismann

Peter Teismann is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 60 papers that have together received 7.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (30 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Genetic Neurodegenerative Diseases (10 papers), Nerve injury and regeneration (9 papers), Nuclear Receptors and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Neurology (2.5k citations), Neurology (3.2k citations) and Cellular and Molecular Neuroscience (2.6k citations). Peter Teismann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Serge Przedborski, Miquel Vila, Kim Tieu, Vernice Jackson‐Lewis, Dong‐Kug Choi, Boris Ferger, Jörg B. Schulz, Du‐Chu Wu, Harry Ischiropoulos and Heather L. Martin. Their work appears in journals such as Annals of Neurology, Journal of Neurochemistry, Proceedings of the National Academy of Sciences, Neurobiology of Disease and Naunyn-Schmiedeberg s Archives of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact